Lilly.com | Eli Lilly and Company
Dec 17, 2024 · Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio® (abemaciclib) in Patients with ER+, HER2- Advanced Breast Cancer
All News - Eli Lilly and Company
Lilly's latest press releases, stories, news resources and more.
Lilly's muvalaplin lowered lipoprotein(a) levels in adults with high ...
Nov 18, 2024 · For further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events ...
Lilly.com | Eli Lilly and Company
Nov 19, 2024 · INDIANAPOLIS , Aug. 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Marschall S. Runge , M.D., Ph.D. is retiring from his role as an independent director of Lilly's board of directors effective Aug. 31, 2024 .
Lilly announces new $4.5 billion site - the Lilly Medicine Foundry
Oct 2, 2024 · Indiana facility will combine research, manufacturing and the latest technology to innovate new production methods and scale global access to clinical supply for Lilly's growing pipeline . Opening in late 2027, the facility will increase Lilly's total capital commitment in the United States to more than $23 billion since 2020
News Release - Eli Lilly and Company
May 24, 2024 · Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history. Since 2020, the company has committed more than $18 billion to build, upgrade and acquire facilities in the U.S. and Europe . INDIANAPOLIS, May 24, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has more than doubled its investment in its Lebanon, Indiana ...
Eli Lilly and Company (LLY) Latest Press Releases & Corporate News …
Get the latest Eli Lilly and Company (LLY) stock news and headlines to help you in your trading and investing decisions.
Lilly reports Q3 2024 financial results highlighted by strong …
Oct 30, 2024 · Eli Lilly and Company (NYSE: LLY) today announced its financial results for the third quarter of 2024.
Eli Lilly and Company (LLY) Latest Stock News & Headlines
Get the latest Eli Lilly and Company (LLY) stock news and headlines to help you in your trading and investing decisions.
Lilly asks to join lawsuit over compounded versions of its weight …
5 days ago · Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...